We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group Expands Equity Derivatives With New Factor Futures
Read MoreHide Full Article
Key Takeaways
CME launched E-mini Equity Factor futures covering Growth, Value, Quality and other strategies.
CME's factor futures offer margin offsets with other cleared equity products to improve capital efficiency.
CME give institutional investors flexible execution through blocks, BTIC and privately negotiated trades.
CME Group Inc. (CME - Free Report) is strengthening its equity derivatives franchise by expanding beyond broad-market exposure into more targeted investment strategies. The company launched its E-mini Equity Factor futures on Sept. 21, giving institutional investors more targeted tools to manage equity exposure and implement factor-based strategies.
The contracts cover E-mini S&P 500 Growth, Value, Quality, Momentum and Low Volatility futures, along with E-mini Dow Jones U.S. Dividend 100 futures. By offering factor-based exposure through futures, CME can help investors hedge or adjust portfolios without trading the underlying securities.
The new contracts are also eligible for margin offsets with other cleared CME equity products, which potentially improves capital efficiency and encourages cross-product trading.
The strategy builds on the company’s June launch of four new E-mini Equity Index futures, highlighting its broader push to expand its benchmark suite and provide more ways to manage equity exposure. This could offer another avenue for volume growth as investors increasingly use factor-based strategies to build portfolios and manage risk.
The contracts are available on CME Globex and through privately negotiated transactions, including block trades, derived futures blocks and BTIC transactions. These trading mechanisms provide institutional participants with greater flexibility in executing larger or customized positions.
For CME, the opportunity will depend on adoption and liquidity. Higher trading activity and open interest could generate additional transaction and clearing revenue while strengthening its equity derivatives ecosystem. If liquidity develops, the contracts could become an additional source of volume growth for CME.
What About Its Peers?
Intercontinental Exchange, Inc. (ICE - Free Report) expanded its derivatives offering in 2026 by launching economic indicator futures tied to central bank policy decisions and U.S. natural gas storage data, giving investors new tools to manage event-driven risks. Its diversified exchange network supports growth in trading and clearing activity.
Cboe Global Markets, Inc. (CBOE - Free Report) expanded its index derivatives offering by launching daily expirations for Dow Jones Industrial Average options in May 2026. Its derivatives business also saw strong activity in August, with record average daily volume in Mini-S&P 500 Index options. Cboe Global’s expansion of listed derivatives provides additional avenues for trading and clearing volume.
CME’s Price Performance
Shares of CME have gained 5.5% over the past year against the industry’s decline of 7.9%.
Image Source: Zacks Investment Research
CME’s Valuation
From a valuation standpoint, CME Group trades at a forward price-to-earnings ratio of 21.75X, higher than the industry average of 20.31X.
Image Source: Zacks Investment Research
CME’s Estimates
The Zacks Consensus Estimate for CME Group’s 2026 and 2027 EPS indicates a year-over-year increase of 9.5% and 4.5%, respectively.
The Zacks Consensus Estimate for 2026 and 2027 earnings has remained unchanged over the past 30 days.
Image Source: Zacks Investment Research
The consensus estimate for revenues in 2026 and 2027 indicates an increase of 7.9% and 4.8%, respectively.
View the Zacks #1 Rank List
Image: Bigstock
CME Group Expands Equity Derivatives With New Factor Futures
Key Takeaways
CME Group Inc. (CME - Free Report) is strengthening its equity derivatives franchise by expanding beyond broad-market exposure into more targeted investment strategies. The company launched its E-mini Equity Factor futures on Sept. 21, giving institutional investors more targeted tools to manage equity exposure and implement factor-based strategies.
The contracts cover E-mini S&P 500 Growth, Value, Quality, Momentum and Low Volatility futures, along with E-mini Dow Jones U.S. Dividend 100 futures. By offering factor-based exposure through futures, CME can help investors hedge or adjust portfolios without trading the underlying securities.
The new contracts are also eligible for margin offsets with other cleared CME equity products, which potentially improves capital efficiency and encourages cross-product trading.
The strategy builds on the company’s June launch of four new E-mini Equity Index futures, highlighting its broader push to expand its benchmark suite and provide more ways to manage equity exposure. This could offer another avenue for volume growth as investors increasingly use factor-based strategies to build portfolios and manage risk.
The contracts are available on CME Globex and through privately negotiated transactions, including block trades, derived futures blocks and BTIC transactions. These trading mechanisms provide institutional participants with greater flexibility in executing larger or customized positions.
For CME, the opportunity will depend on adoption and liquidity. Higher trading activity and open interest could generate additional transaction and clearing revenue while strengthening its equity derivatives ecosystem. If liquidity develops, the contracts could become an additional source of volume growth for CME.
What About Its Peers?
Intercontinental Exchange, Inc. (ICE - Free Report) expanded its derivatives offering in 2026 by launching economic indicator futures tied to central bank policy decisions and U.S. natural gas storage data, giving investors new tools to manage event-driven risks. Its diversified exchange network supports growth in trading and clearing activity.
Cboe Global Markets, Inc. (CBOE - Free Report) expanded its index derivatives offering by launching daily expirations for Dow Jones Industrial Average options in May 2026. Its derivatives business also saw strong activity in August, with record average daily volume in Mini-S&P 500 Index options. Cboe Global’s expansion of listed derivatives provides additional avenues for trading and clearing volume.
CME’s Price Performance
Shares of CME have gained 5.5% over the past year against the industry’s decline of 7.9%.
Image Source: Zacks Investment Research
CME’s Valuation
From a valuation standpoint, CME Group trades at a forward price-to-earnings ratio of 21.75X, higher than the industry average of 20.31X.
Image Source: Zacks Investment Research
CME’s Estimates
The Zacks Consensus Estimate for CME Group’s 2026 and 2027 EPS indicates a year-over-year increase of 9.5% and 4.5%, respectively.
The Zacks Consensus Estimate for 2026 and 2027 earnings has remained unchanged over the past 30 days.
Image Source: Zacks Investment Research
The consensus estimate for revenues in 2026 and 2027 indicates an increase of 7.9% and 4.8%, respectively.
CME currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.